Bhavyas Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.20 Cr
as on 29-07-2024
- Paid Up Capital ₹ 2.15 Cr
as on 29-07-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 86.29%
(FY 2023)
- Profit 131.01%
(FY 2023)
- Ebitda 1100.31%
(FY 2023)
- Net Worth 2335.97%
(FY 2023)
- Total Assets 41.64%
(FY 2023)
About Bhavyas Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.20 Cr and a paid-up capital of Rs 2.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Samba Arigela, Anji Nandipati, and Naresh Ponduri serve as directors at the Company.
- CIN/LLPIN
U24239TG2019PTC132290
- Company No.
132290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bhavyas Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samba Arigela  | Director | 01-Aug-2023 | Current |
| Anji Nandipati | Director | 25-Apr-2019 | Current |
| Naresh Ponduri | Director | Current |
Financial Performance of Bhavyas Pharmaceuticals.
Bhavyas Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 86.29% increase. The company also saw a substantial improvement in profitability, with a 131.01% increase in profit. The company's net worth Soared by an impressive increase of 2335.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhavyas Pharmaceuticals?
In 2023, Bhavyas Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bhavyas Pharmaceuticals?
Bhavyas Pharmaceuticals has a workforce of 8 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhavyas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhavyas Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
